Local Signaling in Diabetic Comorbidities
糖尿病合并症的局部信号传导
基本信息
- 批准号:8891765
- 负责人:
- 金额:$ 33.96万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2015
- 资助国家:美国
- 起止时间:2015-02-10 至 2019-01-31
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
DESCRIPTION (provided by applicant): The spatial and temporal organization of signal transduction pathways influences the precision and fidelity of intracellular events. We have discovered a family of non-catalytic regulatory elements called A-Kinase Anchoring Proteins (AKAPs) that bring together different combinations of calcium- and cAMP-responsive protein kinases and phosphatases to customize the regulation of effector proteins. This application focuses on the molecular pathophysiology of a multivalent anchoring protein known as AKAP79/150 (AKAP79 is the human form, AKAP150 is the murine ortholog). We discovered this protein and defined binding sites for protein kinase A (PKA), the phosphatase PP2B and conventional isoforms of protein kinase C (PKC). Physiological studies have demonstrated that AKAP79/150-tethered enzymes actively participate in the control of glucose homeostasis and coordinate certain extra pancreatic aspects of insulin action. This application is developed around exciting data pertaining to the role of anchored PKC in signaling events that govern arterial constriction and hypertension. Molecular events underlying this pathological state include aberrant calcium influx through ion channels that are controlled, in part, by AKAP79/150-associated PKC. The hypothesis to be tested is that manipulation of anchored PKC affords a measure of vascular benefit to alleviate diabetes-induced hypertension. Two specific aims are proposed: Aim 1: How are individual AKAP79 complexes configured? We will harness three cutting-edge approaches: a) single-molecule pull-down photobleaching (SiMPull) to calculate the range of enzyme combinations on individual anchoring proteins, b) single-particle electron microscopy (EM) to obtain near-atomic structures of higher-order AKAP79 assemblies and c) super resolution imaging of native AKAP-enzyme complexes in vascular smooth muscle. Aim 2: Does PKC-anchoring govern diabetes-related hypertension? Sixty-five percent of diabetics develop hypertension. Our AKAP150-/- and AKAP150ΔPKC knockin mice exhibit lower basal blood pressure suggesting that AKAP-associated PKC participates in the control of vascular tone. Aim 2 will test if selective disruption of this protein-protein interactin reduces vascular tone in mouse models of diabetic hypertension.
描述(通过应用程序提供):信号转导途径的空间和临时组织会影响细胞内事件的精确性和保真度。我们发现了一个称为A-激酶锚定蛋白(AKAP)的非催化调节元件的家族,该元件将钙和cAMP反应性蛋白激酶和磷酸酶的不同组合汇集在一起,以自定义效应蛋白的调节。该应用集中在多价锚定蛋白AKAP79/150的分子病理生理上(AKAP79是人类形式,AKAP150是鼠类直系同源物)。我们发现了蛋白激酶A(PKA),磷酸酶PP2B和蛋白激酶C(PKC)的常规同工型的这种蛋白质和定义的结合位点。生理研究表明,AKAP79/150螺旋酶积极参与葡萄糖稳态和坐标的控制。胰岛素作用的某些额外胰腺方面。该应用是围绕与锚定PKC在控制伪影和高血压的信号事件中的作用有关的令人兴奋的数据开发的。这种病理状态的基础事件包括通过AKAP79/150相关PKC控制的离子通道的异常钙影响。要测试的假设是,对锚定PKC的操纵为减轻糖尿病引起的高血压的血管益处提供了衡量。提出了两个具体目标:目标1:如何配置单个AKAP79复合物? We will harness three cutting-edge approaches: a) single-molecule pull-down photobleaching (SiMPull) to calculate the range of enzyme combinations on individual anchoring proteins, b) single-particle electron microscopy (EM) to obtain near-atomic structures of higher-order AKAP79 assemblies and c) super resolution imaging of native AKAP-enzyme complexes in vascular smooth muscle. AIM 2:PKC锚定是否控制着与糖尿病相关的高血压?百分之六十五的糖尿病患者发展高血压。我们的AKAP150 - / - 和AKAP150ΔPKC敲击蛋白暴露于较低的碱性血压,这表明与AKAP相关的PKC参与了血管张力的控制。 AIM 2将测试该蛋白质蛋白相互作用蛋白的选择性破坏是否会降低糖尿病高血压小鼠模型中的血管张力。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

暂无数据
数据更新时间:2024-06-01
John D Scott其他文献
Large-Scale Telemedicine Implementation for Outpatient Clinicians: Results From a Pandemic-Adapted Learning Collaborative.
门诊临床医生的大规模远程医疗实施:适应大流行的学习协作的结果。
- DOI:
- 发表时间:20242024
- 期刊:
- 影响因子:0
- 作者:David Wong;Israel H Cross;Christian B Ramers;Farah Imtiaz;John D Scott;Amanda M. Dezan;Amy J Armistad;Marie E Manteuffel;Dennis Wagner;Richard C Hunt;William L England;Mei Wa Kwong;Raynald A Dizon;Vanessa Lamers;Ilya Plotkin;B. T. Jolly;Walter Jones;Darin D Daly;Megan Yeager;Jinean A Riley;Elizabeth A. Krupinski;Andrew P Solomon;Katharine H Wibberly;Bruce B. StrumingerDavid Wong;Israel H Cross;Christian B Ramers;Farah Imtiaz;John D Scott;Amanda M. Dezan;Amy J Armistad;Marie E Manteuffel;Dennis Wagner;Richard C Hunt;William L England;Mei Wa Kwong;Raynald A Dizon;Vanessa Lamers;Ilya Plotkin;B. T. Jolly;Walter Jones;Darin D Daly;Megan Yeager;Jinean A Riley;Elizabeth A. Krupinski;Andrew P Solomon;Katharine H Wibberly;Bruce B. Struminger
- 通讯作者:Bruce B. StrumingerBruce B. Struminger
共 1 条
- 1
John D Scott的其他基金
AKAP Modulation of Renal Signaling
肾脏信号传导的 AKAP 调节
- 批准号:1040964410409644
- 财政年份:2019
- 资助金额:$ 33.96万$ 33.96万
- 项目类别:
AKAP Modulation of Renal Signaling
肾脏信号传导的 AKAP 调节
- 批准号:98163769816376
- 财政年份:2019
- 资助金额:$ 33.96万$ 33.96万
- 项目类别:
Defective PKA Signaling in Cushing's Syndrome
库欣综合征中 PKA 信号传导缺陷
- 批准号:97898639789863
- 财政年份:2018
- 资助金额:$ 33.96万$ 33.96万
- 项目类别:
Defective PKA Signaling in Cushing's Syndrome
库欣综合征中 PKA 信号传导缺陷
- 批准号:1045381010453810
- 财政年份:2018
- 资助金额:$ 33.96万$ 33.96万
- 项目类别:
Defective PKA Signaling in Cushing's Syndrome
库欣综合征中 PKA 信号传导缺陷
- 批准号:99817399981739
- 财政年份:2018
- 资助金额:$ 33.96万$ 33.96万
- 项目类别:
Defective PKA Signaling in Cushing's Syndrome
库欣综合征中 PKA 信号传导缺陷
- 批准号:1021549410215494
- 财政年份:2018
- 资助金额:$ 33.96万$ 33.96万
- 项目类别:
Defective PKA Signaling in Cushing's Syndrome
库欣综合征中 PKA 信号传导缺陷
- 批准号:1058298810582988
- 财政年份:2018
- 资助金额:$ 33.96万$ 33.96万
- 项目类别:
Anchored Kinase Signaling Mechanisms in Cardiac Hypertrophy
心脏肥大中的锚定激酶信号传导机制
- 批准号:77722657772265
- 财政年份:2008
- 资助金额:$ 33.96万$ 33.96万
- 项目类别:
Anchored Kinase Signaling Mechanisms in Cardiac Hypertrophy
心脏肥大中的锚定激酶信号传导机制
- 批准号:82307928230792
- 财政年份:2008
- 资助金额:$ 33.96万$ 33.96万
- 项目类别:
Anchored Kinase Signaling Mechanisms in Cardiac Hypertrophy
心脏肥大中的锚定激酶信号传导机制
- 批准号:75729317572931
- 财政年份:2008
- 资助金额:$ 33.96万$ 33.96万
- 项目类别:
相似国自然基金
成人型弥漫性胶质瘤患者语言功能可塑性研究
- 批准号:82303926
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
MRI融合多组学特征量化高级别成人型弥漫性脑胶质瘤免疫微环境并预测术后复发风险的研究
- 批准号:82302160
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
成人免疫性血小板减少症(ITP)中血小板因子4(PF4)通过调节CD4+T淋巴细胞糖酵解水平影响Th17/Treg平衡的病理机制研究
- 批准号:82370133
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
SMC4/FoxO3a介导的CD38+HLA-DR+CD8+T细胞增殖在成人斯蒂尔病MAS发病中的作用研究
- 批准号:82302025
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
融合多源异构数据应用深度学习预测成人肺部感染病原体研究
- 批准号:82302311
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
Effects of early life stress on synaptic function and DA signaling in the VTA
早期生活压力对 VTA 突触功能和 DA 信号传导的影响
- 批准号:88863808886380
- 财政年份:2015
- 资助金额:$ 33.96万$ 33.96万
- 项目类别:
Effects of early life stress on synaptic function and DA signaling in the VTA
早期生活压力对 VTA 突触功能和 DA 信号传导的影响
- 批准号:90574899057489
- 财政年份:2015
- 资助金额:$ 33.96万$ 33.96万
- 项目类别:
Role of the mAKAP Complex in Cardiac Hypertrophy
mAKAP 复合物在心脏肥大中的作用
- 批准号:82999728299972
- 财政年份:2003
- 资助金额:$ 33.96万$ 33.96万
- 项目类别:
Role of the mAKAP Complex in Cardiac Hypertrophy
mAKAP 复合物在心脏肥大中的作用
- 批准号:84723878472387
- 财政年份:2003
- 资助金额:$ 33.96万$ 33.96万
- 项目类别:
Role of the mAKAP Complex in Cardiac Hypertrophy
mAKAP 复合物在心脏肥大中的作用
- 批准号:84711588471158
- 财政年份:2003
- 资助金额:$ 33.96万$ 33.96万
- 项目类别: